|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-8-6
|
|
pubmed:abstractText |
To compare toxicities, disease control, and survival outcomes for patients treated with either cisplatin/irinotecan versus carboplatin/paclitaxel concurrent chemoradiotherapy for locally advanced esophageal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
346-52
|
|
pubmed:meshHeading |
pubmed-meshheading:19841574-Aged,
pubmed-meshheading:19841574-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19841574-Camptothecin,
pubmed-meshheading:19841574-Carboplatin,
pubmed-meshheading:19841574-Cisplatin,
pubmed-meshheading:19841574-Combined Modality Therapy,
pubmed-meshheading:19841574-Esophageal Neoplasms,
pubmed-meshheading:19841574-Female,
pubmed-meshheading:19841574-Follow-Up Studies,
pubmed-meshheading:19841574-Humans,
pubmed-meshheading:19841574-Male,
pubmed-meshheading:19841574-Middle Aged,
pubmed-meshheading:19841574-Neoplasm Staging,
pubmed-meshheading:19841574-Paclitaxel,
pubmed-meshheading:19841574-Retrospective Studies,
pubmed-meshheading:19841574-Survival Rate
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Medical University of South Carolina, Charleston, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
